Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
TXMD is in the long-term up 1183% in 12 years.
Description: TherapeuticsMD, Inc. operates as a women?s health care product company. The company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics. It offers prenatal vitamins, iron supplements, vitamin D supplements, natural menopause relief products, and cosmetic stretch mark creams under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal dryness. TherapeuticsMD markets its products primarily through a direct national sales force to health care providers, as well as directly through its Website. The company was founded in 2008 and is headquartered in Boca Raton, Florida.
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||19.27%||Sales Growth - Q/Q||5.1%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-66.27%||ROE||-75.16%||ROI|
|Current Ratio||8.7||Quick Ratio||8.61||Long Term Debt/Equity||Debt Ratio||0.13|
|Gross Margin||76.69%||Operating Margin||-395.98%||Net Profit Margin||-395.47%||Dividend Payout Ratio|
|Cash From Financing Activities||59.48 M||Cash From Investing Activities||-40 K||Cash From Operating Activities||-19.15 M||Gross Profit||3.43 M|
|Net Profit||-20.89 M||Operating Profit||-20.92 M||Total Assets||99.48 M||Total Current Assets||96.71 M|
|Total Current Liabilities||11.11 M||Total Debt||Total Liabilities||11.77 M||Total Revenue||4.48 M|
|High 52 week||7.42||Low 52 week||3.56||Last close||5.18||Last change||0.97%|
|RSI||78.48||Average true range||0.31||Beta||0.08||Volume||1.72 M|
|Simple moving average 20 days||21.95%||Simple moving average 50 days||14.58%||Simple moving average 200 days||-8.37%|
|Performance Week||16.14%||Performance Month||33.85%||Performance Quart||-6.67%||Performance Half||-22.46%|
|Performance Year||-16.59%||Performance Year-to-date||35.96%||Volatility daily||5%||Volatility weekly||11.17%|
|Volatility monthly||22.9%||Volatility yearly||79.32%||Relative Volume||90.61%||Average Volume||3.32 M|
|New High||New Low|
2019-03-12 10:27:05 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-03-05 08:03:31 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-02-28 07:00:00 | TherapeuticsMD Announces Participation in Two Upcoming Investor Conferences
2019-02-25 09:03:02 | TherapeuticsMD TXMD Catches Eye: Stock Jumps 6.1%
2019-02-22 09:11:53 | TherapeuticsMD, Inc. TXMD Q4 2018 Earnings Conference Call Transcript
2019-02-22 01:46:10 | Edited Transcript of TXMD earnings conference call or presentation 21-Feb-19 9:30pm GMT
2019-02-21 17:59:19 | TherapeuticsMD: 4Q Earnings Snapshot
2019-02-21 16:05:00 | TherapeuticsMD Announces Fourth Quarter and Full-Year 2018 Financial Results
2019-02-21 13:55:44 | Is TherapeuticsMD, Inc.’s NASDAQ:TXMD Balance Sheet Strong Enough To Weather A Storm?
2019-02-08 08:04:46 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-02-08 07:00:00 | TherapeuticsMD to Report Fourth Quarter and Full Year 2018 Results on February 21, 2019
2019-02-04 21:46:00 | Here's What Pushed TherapeuticsMD 37.8% Higher in January
2019-01-17 08:51:01 | Implied Volatility Surging for TherapeuticsMD TXMD Stock Options
2019-01-17 08:06:19 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-01-15 08:03:20 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-01-10 15:17:00 | Why TherapeuticsMD's Stock Spiked Today
2019-01-09 08:06:34 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2019-01-03 07:00:00 | TherapeuticsMD Announces Participation at 37th Annual J.P. Morgan Healthcare Conference
2018-12-21 12:40:00 | The Charts of TherapeuticsMD Look Bearish to Me
2018-12-21 07:18:20 | Jim Cramer Weighs In On Palo Alto, Blackstone And More
2018-12-20 18:54:00 | Cramer's lightning round: These cybersecurity stocks are the ones to own in this market
2018-12-20 11:19:29 | Is TherapeuticsMD Inc TXMD A Good Stock To Buy?
2018-12-15 08:03:07 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2018-12-03 08:00:00 | Detailed Research: Economic Perspectives on TESARO, Regeneron Pharmaceuticals, Pool, Zebra Technologies, Cadence Design, and TherapeuticsMD — What Drives Growth in Today's Competitive Landscape
2018-11-19 13:00:44 | Fast-growing pharmaceutical company signs $20M lease to expand Boca Raton HQ
2018-11-12 16:30:00 | TherapeuticsMD Announces Participation in Three Upcoming Investor Conferences
2018-11-08 03:53:28 | Edited Transcript of TXMD earnings conference call or presentation 7-Nov-18 9:30pm GMT
2018-11-07 18:12:37 | TherapeuticsMD: 3Q Earnings Snapshot
2018-11-07 16:05:00 | TherapeuticsMD Announces Third Quarter 2018 Financial Results
2018-11-06 13:12:26 | TherapeuticsMD Inc’s NASDAQ:TXMD Profit Outlook
2018-10-30 07:00:00 | TherapeuticsMD to Report Third Quarter 2018 Financial Results on November 7, 2018
2018-10-29 15:04:00 | Why TherapeuticsMD Is Sinking Despite Sharing Good News
2018-10-29 10:31:02 | TherapeuticsMD TXMD Q3 Earnings Preview: What to Watch Ahead of the Release
2018-10-29 08:00:00 | Today's Research Reports on Trending Tickers: TherapeuticsMD and Horizon Pharma Public
2018-10-29 06:27:37 | U.S. FDA approves TherapeuticsMD's menopause drug
2018-10-25 08:02:20 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
2018-10-24 08:25:00 | Consolidated Research: 2018 Summary Expectations for Novavax, Caesars Entertainment, SeaWorld Entertainment, LendingTree, CVS Health, and TherapeuticsMD — Fundamental Analysis, Key Performance Indications
2018-10-16 06:33:00 | 3 Biotechs Awaiting FDA Approval Decisions
2018-10-11 10:30:00 | Cannabis and Biotech Stocks That Have Run Parabolically
2018-09-28 08:32:00 | Today's Research Reports on Trending Tickers: TherapeuticsMD and Endo International
2018-09-27 16:05:00 | TherapeuticsMD Enters Into Label Discussions for TX-001HR
2018-09-26 08:30:12 | Implied Volatility Surging for TherapeuticsMD TXMD Stock Options
2018-09-25 07:00:00 | TherapeuticsMD to Present at 2018 Cantor Global Healthcare Conference
2018-09-13 07:00:00 | TherapeuticsMD Announces Commercial Availability of Imvexxy™ 4 mcg